High-Dose Biotin and Your Blood Tests UK Guide

Quick answer: The high-dose biotin sold widely in the UK for hair, skin, and nails (typically 5,000–10,000 µg per dose, sometimes labelled “5 mg” or “10 mg”) can falsify many of the blood tests UK labs run every day — including cardiac troponin (used to diagnose a heart attack), TSH and free T4 (thyroid), hCG (pregnancy), parathyroid hormone, and 25(OH) vitamin D. The interference is a chemistry artefact, not a biological effect, and it lasts for several days after the last dose. Stop high-dose biotin at least 48–72 hours before any planned blood test, and tell your GP, phlebotomist, or A&E doctor that you take it. Multivitamin-strength biotin (around 50–100 µg) is very unlikely to cause this problem.

What’s actually happening — the chemistry

Many modern clinical immunoassays — the automated platforms hospital and community labs use to measure hormones, cardiac markers, and pregnancy hormones — are built around the streptavidin–biotin binding system. Streptavidin is a bacterial protein that binds biotin (vitamin B7) extraordinarily tightly, which is why assay manufacturers like to use it: the analyte is captured by a biotin-linked antibody, and streptavidin-coated beads then pull the biotin–antibody–analyte complex out of solution to be measured.

The design assumes the patient’s blood does not contain a large excess of free biotin. When someone takes a 5,000–10,000 µg supplement, serum biotin can rise one or two orders of magnitude above the normal range. That free biotin saturates the streptavidin binding sites on the beads and displaces the labelled reporter the assay relies on.

The direction of the false reading depends on the assay’s format. In a “sandwich” immunoassay (used for larger analytes such as TSH, troponin, hCG, parathyroid hormone), the result is falsely low. In a “competitive” immunoassay (used for smaller analytes such as free T4, free T3, 25(OH) vitamin D, cortisol), the result is falsely high. Avery’s 2019 review in the Annals of Clinical Biochemistry sets out the chemistry in detail and is the standard UK lab-scientist reference. The patient’s own thyroid, troponin, and hCG levels are unchanged — what changes is the lab’s ability to measure them.

Which blood tests are affected

Avery 2019 and Favresse 2018 between them catalogue affected analytes across multiple manufacturer platforms. The categories below are the ones with the most clinically important consequences.

Cardiac troponin (heart attack diagnosis)

This is the most consequential interference. Cardiac troponin (I and T) is the headline blood test for diagnosing acute myocardial infarction in A&E — a rising or elevated level is the chemical signature of heart-muscle damage. Most UK A&E laboratories have historically run troponin on platforms using the streptavidin–biotin chemistry described above.

If a patient has taken a high-dose biotin supplement in the days before presentation, their measured troponin can be falsely low. At the worst end, that means a real heart attack is not diagnosed. The FDA issued public safety communications on this risk in November 2017 and an updated communication in November 2019, citing a death linked to a missed myocardial infarction in a patient on high-dose biotin. Roche, the dominant supplier of immunoassay platforms in UK NHS labs, introduced biotin-tolerant troponin chemistry (Elecsys II) in 2019; many but not all UK labs have since migrated.

Thyroid function (TSH, free T4, free T3)

Thyroid panels are among the most commonly ordered UK blood tests. TSH is run as a sandwich assay; free T4 and free T3 as competitive assays. Biotin interference therefore typically produces the pattern low TSH, high free T4, high free T3 — the chemical signature of thyrotoxicosis seen in Graves’ disease. Elston and colleagues’ 2016 case report in the Journal of Clinical Endocrinology & Metabolism described exactly this picture in a patient on high-dose biotin: factitious Graves’ disease driven entirely by assay interference, with results normalising once biotin was stopped. Favresse and colleagues’ 2018 review in Endocrine Reviews reports that around half of biotin-thyroid interference cases led to inappropriate treatment or further investigation before the cause was identified, and describes a detection algorithm UK NHS labs broadly follow when results do not match the clinical picture.

Pregnancy (hCG)

The quantitative serum hCG test is run as a sandwich assay on the same platforms. Biotin interference produces a falsely low hCG. Two distinct clinical risks follow: an early pregnancy can be missed if the test reports below the detection threshold, and a suspected ectopic pregnancy can be mismanaged if a falsely low hCG suggests a less urgent picture than the patient actually presents. Home pregnancy tests use a different (qualitative) format and are largely unaffected; the issue is with the quantitative serum tests done in clinical assessment.

Other affected assays

Avery 2019 lists a substantial further set of analytes for which biotin interference has been documented. The most clinically important on a UK pathway:

Parathyroid hormone (PTH) — falsely low; relevant in calcium-disorder workups.
25(OH) vitamin D — falsely high; can mask a true deficiency.
Ferritin — falsely low; iron-status workups.
Cortisol — falsely high; adrenal-function workups.
BNP / NT-proBNP — falsely low; heart-failure markers.
Sex hormones — testosterone, oestradiol, FSH, LH, prolactin.
Tumour markers — CEA, CA-125, AFP, PSA on some platforms.

Different manufacturers and reagent generations have different susceptibility, so the exact list for a given UK lab depends on the platform. The practical rule is the same: if you take high-dose biotin, mention it before any blood test.

The dose threshold — how much biotin is too much

The UK Nutrient Reference Value for biotin is 50 µg per day. Most adults eating a varied UK diet meet this easily from food. To carry the GB-authorised “maintenance of normal hair and skin” claim, a supplement needs only 7.5 µg per portion (15% of the NRV). Multivitamin-strength biotin sits roughly in the 30–100 µg per day band and is very unlikely to cause assay interference.

The problem dose range is the high-strength “hair, skin and nails” market: 5,000–10,000 µg per day, often labelled “5 mg” or “10 mg” — 100 to 200 times the NRV. Below about 1,000 µg per day interference is uncommon; above 5,000 µg per day it is the common case in the published series. The exact threshold depends on dose, time since the last dose, the assay manufacturer, the specific test, and individual biotin metabolism. The practical safe rule is to treat any product at 1,000 µg or more per dose as “high enough to matter for blood tests”.

How long to stop biotin before a blood test

Serum biotin has a half-life of about two hours, but the practical clearance window is longer because biotin distributes into tissues and is then released slowly. Most UK NHS labs and the Association for Clinical Biochemistry & Laboratory Medicine recommend stopping high-dose biotin at least 48 hours before any planned blood test, with some labs requiring 72 hours or more (particularly at 10,000 µg/day or chronic use). When in doubt, take the longer window. This is the rule for planned tests; emergency and urgent testing cannot wait, which is why telling the team you take biotin matters even more in that setting.

What to do if you’ve already taken biotin and need a blood test

If you take high-dose biotin and have dosed within the last 48–72 hours when a blood test is needed, the right action depends on whether the test is planned or emergency.

Planned tests (a routine GP appointment, a thyroid recheck, a vitamin D screen): tell the GP receptionist or phlebotomist that you take biotin and ask whether the appointment should be moved by a couple of days. Most surgeries rebook without complication. If you cannot rebook, tell the phlebotomist anyway — they will note it on the request form so the lab can interpret the result with caution or rerun on a biotin-tolerant assay.

Emergency presentations (chest pain, suspected pregnancy complication, suspected thyroid storm): do not delay going to A&E or calling 999. Tell the doctor or paramedic at the earliest opportunity that you take biotin and at what dose. Many UK A&E labs now run troponin on biotin-tolerant chemistry; even where they do not, your supplement history lets the team interpret the result correctly rather than miss a diagnosis. The single worst response is to stop biotin and then go silent — biotin clears over days, not hours, and the consultant needs to know what was on board.

If a result comes back unexpectedly out of range and you take biotin, ask the clinician whether biotin interference could be contributing. UK NHS labs can rerun affected samples on biotin-tolerant assays where available, or repeat after a 48–72 hour washout.

The marketing dissonance — what biotin is actually authorised to claim

It is worth pausing on why most UK shoppers are taking 5,000–10,000 µg of biotin in the first place. The marketing answer is hair, skin, and nails; the evidence answer is more conservative.

Patel, Swink, and Castelo-Soccio’s 2017 review in Skin Appendage Disorders concluded there is no high-quality randomised controlled trial showing biotin supplementation improves hair growth or density in healthy non-deficient adults. The clearest cases of biotin-responsive alopecia are in inherited biotin-handling disorders, acquired deficiency states (long-term anticonvulsant use, prolonged total parenteral nutrition without biotin, sustained raw-egg-white diets), and infants. The two older case series often quoted in marketing — Hochman 1993 in Cutis and Floersheim 1989 — were uncontrolled, no placebo arm, at 2.5 mg/day for around six months in patients with brittle nails specifically. The signal underwrites the GB-authorised “maintenance of normal hair and skin” claim but does not support marketing biotin as a remedy for thinning hair or weak nails in unselected adults.

The position to step back to: the marketing dose for “hair growth” is the dose at which the lab-test interference happens, and the evidence that the high dose adds anything over a 50–100 µg “meet the NRV” dose in healthy adults is not there.

What the GB Nutrition and Health Claims Register actually allows

The full list of GB-authorised health claims for biotin, verbatim from the GB Nutrition and Health Claims Register (assimilated from EU Regulation 432/2012 post-Brexit), each conditional on the supplement providing at least 7.5 µg per recommended daily portion (15% of the 50 µg NRV):

Biotin contributes to the maintenance of normal hair.
Biotin contributes to the maintenance of normal skin.
Biotin contributes to the maintenance of normal mucous membranes.
Biotin contributes to normal energy-yielding metabolism.
Biotin contributes to normal functioning of the nervous system.
Biotin contributes to normal macronutrient metabolism.
Biotin contributes to normal psychological function.

These are function-of-adequacy claims — the body needs biotin for these processes to work. They are not “more biotin makes hair grow faster” claims, and the GB register does not authorise that wording. The 7.5 µg threshold is the regulatory minimum to carry the claim; the 5,000–10,000 µg products on UK shelves carry the same claim, with the same wording, off the same chemistry. The marketing intensifier is the dose, not the claim.

Talk to your pharmacist or GP if

You are scheduled for any blood test — cardiac troponin, thyroid TSH and free T4, hCG (pregnancy), parathyroid hormone, vitamin D, ferritin, or any tumour marker — and you take biotin at 1,000 µg per day or above.
You are pregnant, planning pregnancy, or breastfeeding — pregnancy is not a context for megadose biotin, and the hCG interference matters specifically here.
You are presenting to A&E with chest pain, palpitations, or any cardiac symptom and have taken biotin in the past few days — tell the team straight away.
A blood-test result has come back unexpectedly out of range and you take high-dose biotin — ask whether the result could be affected.
Your hair, skin, or nails are changing — there are diagnosable medical causes (thyroid disease, iron deficiency, post-pregnancy telogen effluvium, certain medicines) that biotin will not address, and biotin can mask the lab tests that would diagnose them.
You take long-term anticonvulsants (phenytoin, carbamazepine, primidone, phenobarbital) — supplementation here is a clinical question, not an over-the-counter one.
You are considering long-term high-dose biotin (≥5,000 µg per day) for any reason — talk to your pharmacist or GP first.

Sources and further reading

Camden Medicals editorial. Information, not medical advice — talk to your pharmacist or GP if you take biotin and have an upcoming blood test, and never delay an emergency presentation because of a supplement question. If you suspect a side effect from a medicine or supplement, report it via the Yellow Card scheme.

High-Dose Biotin and Your Blood Tests: Why Your Supplement Might Skew a Heart-Attack Diagnosis

What’s actually happening — the chemistry

Which blood tests are affected